Literature DB >> 19078915

Effects of pentoxifylline and n-acetylcysteine on injuries caused by ischemia and reperfusion of splanchnic organs in rats.

N Freire Cerqueira1, C A Hussni, W Bonetti Yoshida, J Lopes Sequeira, C R Padovani.   

Abstract

AIM: Occlusion and reperfusion of splanchnic arteries cause local and systemic changes due to the release of cytotoxic substances and the interaction between neutrophils and endothelial cells. This study evaluated the role of pentoxifylline (PTX) and n-acetylcysteine (NAC) in the reduction of ischemia, reperfusion shock and associated intestinal injury.
METHODS: Sixty rats were divided into 6 groups of 10 animals. Rats in three groups underwent mesenteric ischemia for 30 minutes followed by 120 minutes of reperfusion, and were treated with saline (SAL-5 mL/kg/h), pentoxifylline (PTX-50 mg/kg) or n-acetylcysteine (NAC-430 mg/kg/h). The other 3 groups underwent sham ischemia and reperfusion (I/R) and received the same treatments. Hemodynamic, biochemical and histological parameters were evaluated.
RESULTS: No significant hemodynamic or intestinal histological changes were seen in any sham group. No histological changes were found in the lung or liver of animals in the different groups. There was a progressive decrease in mean arterial blood pressure, from mean of 111.53 mmHg (30 minutes of ischemia) to 44.30+/-19.91 mmHg in SAL-I/R, 34.52+/-17.22 mmHg in PTX-I/R and 33.81+/-8.39 mmHg in NAC-I/R (P<0.05). In all I/R groups, there was a progressive decrease in: aortic blood flow, from median baseline of 19.00 mL/min to 2.50+/-5.25 mL/min in SAL-I/R; 2.95+/-6.40 mL/min in PTX-I/R and 3.35+/-3.40 mL/min in NAC-I/R (P<0.05); in the heart rate, from mean baseline of 311.74 bpm to 233.33+/-83.88 bpm in SAL-I/R, 243.20+/-73.25 bpm in PTX-I/R and 244.92+/-76.05 bpm in NAC-I/R (P<0.05); and esophageal temperature, from mean baseline of 33.68 degrees C to 30.53+/-2.05 degrees C in SAL-I/R, 30.69+/-2.21 degrees C in PTX-I/R and 31.43+/-1.03 degrees C in NAC-I/R (P<0.05). In the other hand, there was an attenuation of mucosal damage in the small intestine of the animals receiving PTX, and only in the ileum of the animals receiving NAC. No changes were found in ileum or plasma malondialdehyde levels in any group.
CONCLUSIONS: PTX was more efficient in reducing histological lesions than NAC, but neither treatment prevented hemodynamic changes during splanchnic organs I/R.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19078915

Source DB:  PubMed          Journal:  Int Angiol        ISSN: 0392-9590            Impact factor:   2.789


  5 in total

1.  Loss of the intestinal mucus layer in the normal rat causes gut injury but not toxic mesenteric lymph nor lung injury.

Authors:  Susan M Sharpe; Xiaofa Qin; Qi Lu; Eleonora Feketeova; David C Palange; Wei Dong; Sharvil U Sheth; Marlon A Lee; Diego Reino; Da-Zhong Xu; Edwin A Deitch
Journal:  Shock       Date:  2010-11       Impact factor: 3.454

2.  The mucus layer is critical in protecting against ischemia-reperfusion-mediated gut injury and in the restitution of gut barrier function.

Authors:  Xiaofa Qin; Sharvil U Sheth; Susan M Sharpe; Wei Dong; Qi Lu; Dazhong Xu; Edwin A Deitch
Journal:  Shock       Date:  2011-03       Impact factor: 3.454

3.  Intraportal versus Systemic Pentoxifylline Infusion after Normothermic Liver Ischemia: Effects on Regional Blood Flow Redistribution and Hepatic Ischemia-Reperfusion Injury.

Authors:  Edson A Ribeiro; Luiz F Poli-de-Figueiredo; Rodrigo Vincenzi; Flavio H F Galvao; Nelson Margarido; Mauricio Rocha-E-Silva; Ruy J Cruz
Journal:  HPB Surg       Date:  2013-08-29

Review 4.  Pentoxifylline for vascular health: a brief review of the literature.

Authors:  Mark F McCarty; James H O'Keefe; James J DiNicolantonio
Journal:  Open Heart       Date:  2016-02-08

5.  Glutamine prevents oxidative stress in a model of portal hypertension.

Authors:  Gilmara Pandolfo Zabot; Gustavo Franco Carvalhal; Norma Possa Marroni; Francielli Licks; Renata Minuzzo Hartmann; Vinícius Duval da Silva; Henrique Sarubbi Fillmann
Journal:  World J Gastroenterol       Date:  2017-07-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.